Skip to content
Search

Latest Stories

England sees net loss of 101 pharmacies in 2023, FOI request reveals

In its response to a Freedom of Information Request (FOI), the NHS Business Services Authority (NHSBSA) has confirmed a net decrease of 101 pharmacies in England — with 371 closures and 270 new contracts for the year ending March 31, 2023, compared to the preceding year. Meanwhile, the General Pharmaceutical Council data projected a drop of 43 registered pharmacies in England, Wales, and Scotland during the same period.

The data, released by business advisor Christie & Co in its annual pharmacy market review on Sept. 5, revealed a total of 14,328 pharmacies across all four UK country regions as of March 31, 2023, indicating a 0.3 per cent decrease from the previous year. Corporate operators experienced a net reduction of 249 pharmacies, while the total number of independent operators remained consistent with 2022.


According to the study, the corporate sector saw the most substantial shift, with a 13.7 per cent reduction in businesses operating 300 or more pharmacies. Following closely, groups managing 11 to 15 pharmacies experienced a 5.6 per cent decrease. Christie & Co attributed this shift in group size to operators acquiring additional pharmacies through corporate disposal opportunities throughout the year.

The report noted that on a contract-type basis, it's worth acknowledging that only England has 100-hour and distance selling contracts among the 11,779 registered pharmacies. Additionally, the report emphasised that the sector is primarily dominated by regional multiples, with companies managing over 300 pharmacies constituting only about 34 per cent of the overall market.

Rising wages spark employment worries

Recent reports from the Office for National Statistics indicated a record 7.8 per cent annual wage growth in the UK up to June 2023. This surge has compounded employment challenges, establishing it as one of the most pressing cost issues in the sector, Christie & Co said in its study.

The report highlighted that pharmacists and qualified staff are increasingly attracted to roles in GP surgeries and PCNs due to the ongoing Additional Roles Reimbursement Scheme. Referring to data released in NHS England’s May 2023 Primary Care Workforce Quarterly Update, the report noted that 6,331 FTE pharmacists and 2,124 pharmacy technicians have embraced roles under this scheme.

While this aids the government's commitment to enlist 26,000 new staff in general practice by 2024, it offers no relief to the ongoing employment crisis faced by the pharmacy sector, the report noted.

Surge in locum demand

Although some contractors discussed a brief alleviation in locum costs in the first half of 2023, workforce demands persistently propel locum rate hikes in three of the four UK country regions. Notably, only Scotland saw a reduction, with average rates declining from £48.86 in July 2022 to £45.36 in July 2023, the study said.

According to data from Locate a Locum, average locum rates in England, Wales, and Northern Ireland increased to £37.14, £42.60, and £28.66 respectively. Analysis of 160,000 pharmacy shifts between June 2022 and July of this year, conducted by Locate a Locum, revealed an average hourly rate of £38.44 for a locum pharmacist in the UK.

Looking at UK towns and cities, this data sample indicates an average increase of 3.5 per cent in locum rates overall. However, there are notable variations. Inverness saw the most significant drop, averaging at 14.8 per cent, while Cardiff experienced the highest increase at an average of 30.3 per cent.

"Regional variations highlight market complexities, local challenges, and widespread NHS pressures," said Jonathon Clarke, CEO of Locate a Locum. "Community pharmacies grapple with heightened dispensing demands while steadfastly supporting NHS services. This occurs amidst a backdrop of reduced funding, drug shortages, and store closures. Market dynamics are leaning more heavily on locums to sustain operational continuity. Notably, we've seen an uptick in negotiations between pharmacies and locum pharmacists, aiming to enhance shift fill rates and subsequently decrease the necessity for emergency cover."

Meanwhile, the Royal Pharmaceutical Society and Pharmacist Support charity have underscored the vital importance of safeguarding pharmacy teams from burnout to ensure uninterrupted patient safety. Their report, 'Pharmacy Workforce Wellbeing', published on October 4, emerged from a May 2023 roundtable event with representatives from various sectors. It highlighted the pressing need for strategic solutions, addressing rising workloads and limited capacity in community pharmacies. The report suggested optimising skill mix and incorporating advanced technologies as avenues for capacity enhancement.

More For You

Beware of wage theft: PDA warns locums

Booking terms should clearly outline not only the dates of work, shift times, and rate of pay but also the required notice period

Getty Images

PDA warns locum pharmacists of ‘wage theft’ risk

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to check booking terms carefully before accepting shifts, warning of the risk of ‘wage theft’ and delayed payments.

According to the union, locum members have reported being owed significant unpaid fees for services provided, with some pharmacists claiming debts exceeding £20,000."

Keep ReadingShow less
UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less